|
1
|
Friedman SL, Maher JJ and Bissell DM:
Mechanisms and therapy of hepatic fibrosis: Report of the AASLD
single topic basic research conference. Hepatology. 32:1403–1408.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pellicoro A, Ramachandran P, Iredale JP
and Fallowfield JA: Liver fibrosis and repair: Immune regulation of
wound healing in a solid organ. Nat Rev Immunol. 14:181–194. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Puche JE, Saiman Y and Friedman SL:
Hepatic stellate cells and liver fibrosis. Compr Physiol.
3:1473–1492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duval F, Moreno-Cuevas JE, González-Garza
MT, Rodríguez-Montalvo C and Cruz-Vega DE: Liver fibrosis and
protection mechanisms action of medicinal plants targeting
apoptosis of hepatocytes and hepatic stellate cells. Adv Pharmacol
Sci. 2014:3732952014.PubMed/NCBI
|
|
5
|
Breitkopf K, Roeyen CV, Sawitza I, Wickert
L, Floege J and Gressner AM: Expression patterns of PDGF-A, -B, -C
and -D and the PDGF-receptors alpha and beta in activated rat
hepatic stellate cells (HSC). Cytokine. 31:349–357. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang L, Zhan S, Huang C, Cheng X, Lv X, Si
H and Li J: TRPM7 channel regulates PDGF-BB-induced proliferation
of hepatic stellate cells via PI3 K and ERK pathways. Toxicol Appl
Pharmacol. 272:713–725. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shah R, Reyes-Gordillo K,
Arellanes-Robledo J, Lechuga CG, Hernández-Nazara Z, Cotty A,
Rojkind M and Lakshman MR: TGF-β 1 up-regulates the expression of
PDGF-β receptor mRNA and induces a delayed PI3K-, AKT- and p70
S6K-dependent proliferative response in activated hepatic stellate
cells. Alcohol Clin Exp Res. 37:1838–1848. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miao CG, Yang YY, He X, Huang C, Huang Y,
Zhang L, Lv XW, Jin Y and Li J: Wnt signaling in liver fibrosis:
Progress, challenges and potential directions. Biochimie.
95:2326–2335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Harthi L: Wnt/β-catenin and its diverse
physiological cell signaling pathways in neurodegenerative and
neuropsychiatric disorders. J Neuroimmune Pharmacol. 7:725–730.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ge WS, Wang YJ, Wu JX, Fan JG, Chen YW and
Zhu L: β-catenin is overexpressed in hepatic fibrosis and blockage
of Wnt/β-catenin signaling inhibits hepatic stellate cell
activation. Mol Med Rep. 9:2145–2151. 2014.PubMed/NCBI
|
|
12
|
Rashid ST, Humphries JD, Byron A, Dhar A,
Askari JA, Selley JN, Knight D, Goldin RD, Thursz M and Humphries
MJ: Proteomic analysis of extracellular matrix from the hepatic
stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel
constituents of fibrotic liver. J Proteome Res. 11:4052–4064. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
MadanKumar P, NaveenKumar P, Manikandan S,
Devaraj H and NiranjaliDevaraj S: Morin ameliorates chemically
induced liver fibrosis in vivo and inhibits stellate cell
proliferation in vitro by suppressing Wnt/β-catenin signaling.
Toxicol Appl Pharmacol. 277:210–220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin HW, Park SY, Lee KB, Shin E, Nam SW,
Lee JY and Jang JJ: Transcriptional profiling and Wnt signaling
activation in proliferation of human hepatic stellate cells induced
by PDGF-BB. Korean J Hepatol. 15:486–495. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saneyoshi T, Kume S, Amasaki Y and
Mikoshiba K: The Wnt/calcium pathway activates NF-AT and promotes
ventral cell fate in Xenopus embryos. Nature. 417:295–299. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei F, Lang Y, Gong D and Fan Y: Effect of
Dahuang zhechong formula on liver fibrosis in patients with chronic
hepatitis B: A meta-analysis. Complement Ther Med. 23:129–138.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin HJ, Chen JY, Lin CF, Kao ST, Cheng JC,
Chen HL and Chen CM: Hepatoprotective effects of Yi Guan Jian, an
herbal medicine, in rats with dimethylnitrosamine-induced liver
fibrosis. J Ethnopharmacol. 134:953–960. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu TT, Jiang MN, Li C, Che Y and Jia YJ:
Effect of Chinese traditional compound, Gan-fu-kang, on
CCl(4)-induced liver fibrosis in rats and its probable molecular
mechanisms. Hepatol Res. 37:221–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lou JL, Jiang MN, Li C, Zhou Q, He X, Lei
HY, Li J and Jia YJ: Herb medicine Gan-fu-kang attenuates liver
injury in a rat fibrotic model. J Ethnopharmacol. 128:131–138.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang C, Wang Y, Chen H, Yang G, Wang S,
Jiang M, Cong L, Yuan L, Li H and Jia Y: Protective effect of the
herbal medicine Gan-fu-kang against carbon tetrachloride-induced
liver fibrosis in rats. Mol Med Rep. 8:954–962. 2013.PubMed/NCBI
|
|
21
|
National Institutes of Health: Guide for
the Care and Use of Laboratory Animals. 6th edition. National
Academies Press; Washington, DC: 1985
|
|
22
|
Scheuer PJ: Classification of chronic
viral hepatitis: A need for reassessment. J Hepatol. 13:372–374.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zakaria S, Youssef M, Moussa M, Akl M,
El-Ahwany E, El-Raziky M, Mostafa O, Helmy AH and El-Hindawi A:
Value of α-smooth muscle actin and glial fibrillary acidic protein
in predicting early hepatic fibrosis in chronic hepatitis C virus
infection. Arch Med Sci. 6:356–365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schiavon F: Transient joint effusion: A
forgotten side effect of high dose corticosteroid treatment. Ann
Rheum Dis. 62:491–492. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun WY, Wang L, Liu H, Li X and Wei W: A
standardized extract from Paeonia lactiflora and Astragalus
membranaceus attenuates liver fibrosis induced by porcine serum in
rats. Int J Mol Med. 29:491–498. 2012.
|
|
26
|
Lee HS, Son WC, Ryu JE, Koo BA and Kim YS:
Standardized Salvia miltiorrhiza extract suppresses hepatic
stellate cell activation and attenuates steatohepatitis induced by
a methionine-choline deficient diet in mice. Molecules.
19:8189–8211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin C, Zhang PJ, Bao CQ, Gu YL, Xu BH, Li
CW, Li JP, Bo P and Liu XN: Protective effects of Atractylodes
macrocephala polysaccharide on liver ischemia-reperfusion injury
and its possible mechanism in rats. Am J Chin Med. 39:489–502.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu PS, Wu SJ, Tsai YH, Lin YH and Chao JC:
Hot water extracted Lycium barbarum and Rehmannia glutinosa inhibit
liver inflammation and fibrosis in rats. Am J Chin Med.
39:1173–1191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hajiaghamohammadi AA, Ziaee A and Samimi
R: The efficacy of licorice root extract in decreasing transaminase
activities in non-alcoholic fatty liver disease: A randomized
controlled clinical trial. Phytother Res. 26:1381–1384. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hofman K, Hall B, Cleaver H and Marshall
S: High-throughput quantification of hydroxyproline for
determination of collagen. Anal Biochem. 417:289–291. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song P, Zheng JX, Xu J, Liu JZ, Wu LY and
Liu C: β-catenin induces A549 alveolar epithelial cell mesenchymal
transition during pulmonary fibrosis. Mol Med Rep. 11:2703–2710.
2015.
|
|
32
|
Ye B, Ge Y, Perens G, Hong L, Xu H,
Fishbein MC and Li F: Canonical Wnt/β-catenin signaling in
epicardial fibrosis of failed pediatric heart allografts with
diastolic dysfunction. Cardiovasc Pathol. 22:54–57. 2013.
View Article : Google Scholar
|
|
33
|
Li X, Yamagata K, Nishita M, Endo M,
Arfian N, Rikitake Y, Emoto N, Hirata K, Tanaka Y and Minami Y:
Activation of Wnt5a-Ror2 signaling associated with
epithelial-to-mesenchymal transition of tubular epithelial cells
during renal fibrosis. Genes Cells. 18:608–619. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li W, Zhu C, Li Y, Wu Q and Gao R: Mest
attenuates CCl4-induced liver fibrosis in rats by inhibiting the
Wnt/β-catenin signaling pathway. Gut Liver. 8:282–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang F, Parsons CJ and Stefanovic B: Gene
expression profile of quiescent and activated rat hepatic
stellate-cells implicates Wnt signaling pathway in activation. J
Hepatol. 45:401–409. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sheldahl LC, Park M, Malbon CC and Moon
RT: Protein kinase C is differentially stimulated by Wnt and
Frizzled homologs in a G-protein-dependent manner. Curr Biol.
9:695–698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
De A: Wnt/Ca2+ signaling
pathway: A brief overview. Acta Biochim Biophys Sin (Shanghai).
43:745–756. 2011. View Article : Google Scholar
|
|
38
|
Buchholz M, Schatz A, Wagner M, Michl P,
Linhart T, Adler G, Gress TM and Ellenrieder V: Overexpression of
c-myc in pancreatic cancer caused by ectopic activation of NFATc1
and the Ca2+/calcineurin signaling pathway. EMBO J.
25:3714–3724. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kohn AD and Moon RT: Wnt and calcium
signaling: Beta-catenin-independent pathways. Cell Calcium.
38:439–446. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim J, Kim DW, Chang W, Choe J, Kim J,
Park CS, Song K and Lee I: Wnt5a is secreted by follicular
dendritic cells to protect germinal center B cells via
Wnt/Ca2+/NFAT/NF-κB-B cell lymphoma 6 signaling. J
Immunol. 188:182–189. 2012. View Article : Google Scholar
|
